EUCTR2010-020945-28-LVActive, not recruitingNot Applicable
Perindopril arginine/Amlodipine versus Valsartan/Amlodipine antihypertensive strategies: Efficacy and safety in mild to moderate hypertensive patients.A randomised, double blind 6-month study followed by 8-month open label long-term follow-up with Perindopril arginine/Amlodipine.
Institut de Recherches Internationales Servier0 sites1,600 target enrollmentStarted: December 14, 2010Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Enrollment
- 1,600
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •- Outpatients,
- •- Men or women,
- •- 18 years old at least,
- •- Mild to moderate hypertensive patient.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 1000
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 600
Exclusion Criteria
- •- Pregnant or breastfeeding women,
- •- Secondary hypertension,
- •- Any patient suffering from an acute or chronic illness.
Investigators
Similar Trials
Active, not recruiting
Not Applicable
S5985 combination versus Angiotensin II Receptor blocker/Calcium Channel Blocker: a comparison of blood pressure lowering - efficacy and safetyEssential arterial hypertensionMedDRA version: 14.1Level: LLTClassification code 10020775Term: Hypertension arterialSystem Organ Class: 100000004866EUCTR2010-020945-28-PTInstitut de Recherches Internationales Servier1,600
Not yet recruiting
Phase 3
Perindopril arginine/Amlodipine versus Valsartan/Amlodipine antihypertensive startegies: Efficacy and safety in mild to moderate hypertensive patients. A randomised, double blind 6-month study followed by 8-month open label long-term follow-up with Perindopril arginine/Amlodipine.arterial hypertensionhigh blood pressure10057166NL-OMON34436Servier R&D Benelux50
Active, not recruiting
Phase 1
Perindopril arginine/Amlodipine versus Valsartan/Amlodipine antihypertensive strategies: Efficacy and safety in mild to moderate hypertensive patients.A randomised, double blind 6-month study followed by 8-month open label long-term follow-up with Perindopril arginine/Amlodipine.//Estrategias antihipertensivas Perindopril arginina/Amlodipino versus Valsartan/Amlodipino: Eficacia y seguridad en pacientes hipertensos de leves a moderados.Estudio aleatorizado, doble ciego durante 6 meses y que se continúa con un seguimiento a largo plazo en abierto durante 8 meses con Perindopril arginina/AmlodipinoEssential arterial hypertension//Hipertensión arterial esencialMedDRA version: 12.1Level: LLTClassification code 10020775Term: Hypertension arterialEUCTR2010-020945-28-ESItziar Fernandez Gonzalez1,600
Active, not recruiting
Phase 1
S 05985 combination versus Angiotensin II Receptor Blocker/Calcium Channel Blocker : a comparison of blood pressure lowering - efficacy and safetyEUCTR2010-020945-28-GBInstitut de Recherches Internationales Servier1,600
Active, not recruiting
Not Applicable
S05985 combination versus Angiotensin II Receptor Blocker/Calcium Channel Blocker: a comparison of blood pressure lowering - efficacy and safetyEssential arterial hypertensionMedDRA version: 14.0Level: LLTClassification code 10020775Term: Hypertension arterialSystem Organ Class: 10047065 - Vascular disordersEUCTR2010-020945-28-BEInstitut de Recherches Internationales Servier1,600